Radioiodine therapy for metastatic differentiated thyroid cancer: Determination of the maximum safe dose until 48 hours after the administration of a tracer dose

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.